Technical Analysis for WAVE - Waverly Pharma Inc.

Grade Last Price % Change Price Change
F 0.015 0.00% 0.000
WAVE closed up 50.0 percent on Thursday, November 21, 2024, on 5 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 25
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup 50.00%
Wide Bands Range Expansion 50.00%
Gapped Up Strength 50.00%
Oversold Stochastic Weakness 50.00%

   Recent Intraday Alerts

Alert Time
Gapped Up (Full) 18 days ago
Up 1 ATR 18 days ago
Up 5% 18 days ago
Up 3% 18 days ago
Up 2% 18 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Waverley Pharma Inc is a Canada-based company engaged in Biotechnology & Medical Research sector.The Company is focused on developing and commercializing Safe and Effective Small Molecules for Treatment of Cancer. Waverley Pharma is working in collaboration with a Indian conglomerate based in Mumbai to develop products for the treatment of cancer. Two of the lead products under developments are: WAV-101: WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications; WAV-102 is also an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. The Company has signed an agreement with Omgene Life Sciences for the development of another generic anti-cancer product WAV-103.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Occupational Safety And Health Medicine Pharma Labor Drug Biotechnology Science Cancer Life Sciences Therapy Collaboration Oncology Drug Development Lung Cancer Treatment Of Cancer Chemotherapy Non Small Cell Lung Cancer Multiple Myeloma Treatment Of Non Small Cell Lung Cancer

Is WAVE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.13
52 Week Low 0.01
Average Volume 22,048
200-Day Moving Average 0.047
50-Day Moving Average 0.020
20-Day Moving Average 0.016
10-Day Moving Average 0.014
Average True Range 0.005
RSI (14) 48.45
ADX 11.46
+DI 18.006
-DI 31.101
Chandelier Exit (Long, 3 ATRs) 0.011
Chandelier Exit (Short, 3 ATRs) 0.024
Upper Bollinger Bands 0.024
Lower Bollinger Band 0.008
Percent B (%b) 0.45
BandWidth 100.000
MACD Line -0.002
MACD Signal Line -0.002
MACD Histogram -0.0003
Fundamentals Value
Market Cap 810 Thousand
Num Shares 54 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -0.94
Price-to-Sales 6.91
Price-to-Book 3.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.015
Resistance 3 (R3) 0.015 0.015 0.015
Resistance 2 (R2) 0.015 0.015 0.015 0.015
Resistance 1 (R1) 0.015 0.015 0.015 0.015 0.015
Pivot Point 0.015 0.015 0.015 0.015 0.015
Support 1 (S1) 0.015 0.015 0.015 0.015 0.015
Support 2 (S2) 0.015 0.015 0.015 0.015
Support 3 (S3) 0.015 0.015 0.015
Support 4 (S4) 0.015